COVID-19 policy recommendations for OUD, pain, harm reduction
The AMA provides policy recommendations to help guide policymakers reduce the stress of patients with an opioid use disorder and pain during the COVID-19 outbreak.
Policy road map shows the way to end the overdose epidemic
It’s been clear for years that, to end the drug overdose epidemic, health insurance company and pharmacy benefit managers’ barriers to evidence-based treatment and non-opioid pain management must be eliminated.
Medicare & Medicaid
Final 2021 Medicare pay schedule: What physicians need to know
Changes to E/M will ease documentation burdens, but final rule also includes painful pay cuts that Congress must act to avert. Learn more with the AMA.
Overdose epidemic requires state action to remove barriers to care
AMA, Mannatt report emphasizes the increasing importance of removing barriers to evidence-based care.
Nov. 13, 2020: State Advocacy Update
Public-private partnership seeks to build SUD treatment network throughout Georgia and more in the latest State Advocacy Update.
AMA statement on Justice Department settlement with Purdue Pharma
Any settlement should be used exclusively for data collection, research, education, overdose prevention, stigma elimination, and evidence-based treatment.
Physicians’ progress toward ending the nation’s drug overdose and death epidemic
Physicians’ progress toward ending the nation’s drug overdose and death epidemic.
Membership Moves Medicine™
- Free access to JAMA Network™ and CME
- Save hundreds on insurance
- Fight for physicians and patient rights